Your browser doesn't support javascript.
loading
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility.
Rosadas, Carolina; Khan, Maryam; Parker, Eleanor; Marchesin, Federica; Katsanovskaja, Ksenia; Sureda-Vives, Macià; Fernandez, Natalia; Randell, Paul; Harvey, Ruth; Lilley, Alice; Harris, Benjamin H L; Zuhair, Mohamed; Fertleman, Michael; Ijaz, Samreen; Dicks, Steve; Short, Charlotte-Eve; Quinlan, Rachael; Taylor, Graham P; Hu, Kai; McKay, Paul; Rosa, Annachiara; Roustan, Chloe; Zuckerman, Mark; El Bouzidi, Kate; Cooke, Graham; Flower, Barnaby; Moshe, Maya; Elliott, Paul; Spencer, Alexandra J; Lambe, Teresa; Gilbert, Sarah C; Kingston, Hugh; Baillie, J Kenneth; Openshaw, Peter J M; Semple, Malcolm G; Cherepanov, Peter; McClure, Myra O; Tedder, Richard S.
Afiliação
  • Rosadas C; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Khan M; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Parker E; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Marchesin F; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Katsanovskaja K; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Sureda-Vives M; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Fernandez N; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Randell P; Department of Infection and Immunity, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, W6 8RF, UK.
  • Harvey R; Worldwide Influenza Centre, Francis Crick Institute, London, NW1 1AT, UK.
  • Lilley A; Worldwide Influenza Centre, Francis Crick Institute, London, NW1 1AT, UK.
  • Harris BHL; The Wellington Hospital, Circus Road, St John's Wood, London, NW8 6PD, UK; Computational Biology and Integrative Genomics, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
  • Zuhair M; The Wellington Hospital, Circus Road, St John's Wood, London, NW8 6PD, UK.
  • Fertleman M; The Wellington Hospital, Circus Road, St John's Wood, London, NW8 6PD, UK.
  • Ijaz S; Blood Borne Virus Unit, National Infection Service, Colindale Public Health England, London, NW9 5EQ, UK.
  • Dicks S; Blood Borne Virus Unit, National Infection Service, Colindale Public Health England, London, NW9 5EQ, UK; Transfusion Microbiology, NHS Blood and Transplant, Lingard Avenue, London, NW9 5BG, UK.
  • Short CE; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Quinlan R; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Taylor GP; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Hu K; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • McKay P; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Rosa A; Chromatin Structure and Mobile DNA Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Crick COVID19 Consortium, Francis Crick Institute, London, NW1 1AT, UK.
  • Roustan C; Structural Biology Science Technology Platform, Francis Crick Institute, London, NW1 1AT, UK; Crick COVID19 Consortium, Francis Crick Institute, London, NW1 1AT, UK.
  • Zuckerman M; Department of Virology, King's College Hospital, London, SE5 9RS, UK.
  • El Bouzidi K; Department of Virology, King's College Hospital, London, SE5 9RS, UK.
  • Cooke G; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Flower B; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Moshe M; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Elliott P; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Spencer AJ; Jenner Institute, University of Oxford, ORCRB, Oxford, OX3 7DQ, UK.
  • Lambe T; Jenner Institute, University of Oxford, ORCRB, Oxford, OX3 7DQ, UK.
  • Gilbert SC; Jenner Institute, University of Oxford, ORCRB, Oxford, OX3 7DQ, UK.
  • Kingston H; Department of Infection and Immunity, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, W6 8RF, UK.
  • Baillie JK; Roslin Institute, University of Edinburgh, Midlothian, EH25 9RG, UK.
  • Openshaw PJM; National Heart and Lung Institute, Imperial College London, Chelsea, London, SW3 6LY, UK.
  • Semple MG; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, L69 7BE, UK.
  • Cherepanov P; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK; Chromatin Structure and Mobile DNA Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Crick COVID19 Consortium, Francis Crick Institute, London, NW1 1AT, UK.
  • McClure MO; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
  • Tedder RS; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, W2 1PG, UK. Electronic address: r.tedder@imperial.ac.uk.
J Virol Methods ; 302: 114475, 2022 04.
Article em En | MEDLINE | ID: mdl-35077719
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article